Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torgrim Tandstad

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study groupTorgrim Tandstad, Rune Smaaland, Arne Solberg, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 29, 2024
Added Value of [18F]PSMA-1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical ManagementBendik S Abrahamsen, Torgrim Tandstad, Bjørg Y Aksnessæther, et al.
International Journal of Cancer|June 12, 2020
Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: Case reports and review of the literatureLene Thorsen, Hege S Haugnes, Sophie D Fosså, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer GroupSven-Erik Olofsson, Torgrim Tandstad, Mats Jerkeman, et al.
European Urology|April 28, 2026
European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 GuidelinesAnna Patrikidou, Walter Cazzaniga, Christoph Oing, et al.
European Urology|March 16, 2021
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021Christian Daniel Fankhauser, Jan Oldenburg, Peter Albers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillanceChristian Kollmannsberger, Torgrim Tandstad, Philippe L Bedard, et al.
European Urology|May 14, 2023
European Association of Urology Guidelines on Testicular Cancer: 2023 UpdateAnna Patrikidou, Walter Cazzaniga, Daniel Berney, et al.
Frontiers in Oncology|January 11, 2021
Detection of Recurrent Prostate Cancer With <sup>18</sup>F-Fluciclovine PET/MRIKirsten Margrete Selnæs, Brage Krüger-Stokke, Mattijs Elschot, et al.
European Urology Oncology|September 12, 2019
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer GroupAxel Gerdtsson, Ulf Håkansson, Magnus Törnblom, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study groupTorgrim Tandstad, Rune Smaaland, Arne Solberg, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 29, 2024
Added Value of [18F]PSMA-1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical ManagementBendik S Abrahamsen, Torgrim Tandstad, Bjørg Y Aksnessæther, et al.
International Journal of Cancer|June 12, 2020
Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: Case reports and review of the literatureLene Thorsen, Hege S Haugnes, Sophie D Fosså, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer GroupSven-Erik Olofsson, Torgrim Tandstad, Mats Jerkeman, et al.
European Urology|April 28, 2026
European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 GuidelinesAnna Patrikidou, Walter Cazzaniga, Christoph Oing, et al.
European Urology|March 16, 2021
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021Christian Daniel Fankhauser, Jan Oldenburg, Peter Albers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillanceChristian Kollmannsberger, Torgrim Tandstad, Philippe L Bedard, et al.
European Urology|May 14, 2023
European Association of Urology Guidelines on Testicular Cancer: 2023 UpdateAnna Patrikidou, Walter Cazzaniga, Daniel Berney, et al.
Frontiers in Oncology|January 11, 2021
Detection of Recurrent Prostate Cancer With <sup>18</sup>F-Fluciclovine PET/MRIKirsten Margrete Selnæs, Brage Krüger-Stokke, Mattijs Elschot, et al.
European Urology Oncology|September 12, 2019
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer GroupAxel Gerdtsson, Ulf Håkansson, Magnus Törnblom, et al.
Pageof 7